Literature DB >> 21343270

Esophageal stricture associated with alendronate use.

Asit K Paul1, Mysore Seetharaman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21343270      PMCID： PMC3080562          DOI： 10.1503/cmaj.100415

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Reports of esophageal cancer with oral bisphosphonate use.

Authors:  Diane K Wysowski
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

2.  Alendronate--risk for esophageal stricture.

Authors:  Q Y Yue; O Mortimer
Journal:  J Am Geriatr Soc       Date:  1998-12       Impact factor: 5.562

3.  Oesophageal stricture associated with alendronic acid.

Authors:  G Naylor; M H Davies
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

4.  Esophageal stricture associated with alendronate therapy.

Authors:  J Levine; D Nelson
Journal:  Am J Med       Date:  1997-05       Impact factor: 4.965

5.  Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture--radiographic features.

Authors:  J M Ryan; P Kelsey; B M Ryan; P R Mueller
Journal:  Radiology       Date:  1998-02       Impact factor: 11.105
  5 in total
  1 in total

1.  Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate.

Authors:  B T Hardy; J F de Brito Galvao; T A Green; S R Braudaway; S P DiBartola; L Lord; D J Chew
Journal:  J Vet Intern Med       Date:  2015-01-12       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.